Latest Market Segmentation News

Pro Medicus' US arm, Visage Imaging, has landed a substantial 7-year, A$25 million contract to deploy its Visage 7 cloud-based imaging platform across Valley Health's hospital network in Virginia and West Virginia.

Cryosite Limited delivered robust FY26 results with revenue up 18% to $16.7 million and net profit rising 19%, underpinned by a strategic warehouse acquisition that doubled storage capacity and a cool room expansion.

Finbar Group has secured development approval for its Leeder Residences in West Leederville, boosting the project's estimated end value to $265 million. The two-tower development will deliver 244 apartments and is set to start pre-sales in late 2026.

Origin Energy reported a 6% increase in FY26 profit to $1.57 billion despite a 10% revenue drop, advancing renewable projects and extending Eraring Power Station operations, while managing a customer data breach.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

Unith Ltd has launched the alpha version of DEVA-1, a next-generation AI model designed to boost the emotional expressiveness and realism of Digital Human avatars, targeting a rapidly growing market.

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

GALE Pacific reported a robust $4.1 million operating cash inflow in Q4 FY26, culminating in $14.4 million for the full year. The company reduced borrowings by over $12 million, entering FY27 with a net cash position of $4.9 million and renewed focus on growth amid geopolitical uncertainties.

Saluda Medical capped FY26 with a 28% revenue surge, beating guidance at US$90.2 million, while FDA approval for its CAP24 paddle lead opens a new US surgical market segment.

Australian Silica Quartz Group (ASQ) reports promising kaolin beneficiation results from its White Swan Project, with dry processing boosting kaolinite content to 83% and early ceramic tests confirming product quality. Chinese market feedback signals robust demand amid dwindling domestic supplies.

InteliCare generated positive cash flow for the first time since listing in the June 2026 quarter, driven by accelerated deployments across aged care and retirement living sectors.